T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.47B |
| 2 |
NXP Semiconductors
NXPI
|
+$1.73B |
| 3 |
Tesla
TSLA
|
+$1.7B |
| 4 |
Northrop Grumman
NOC
|
+$1.67B |
| 5 |
Dollar Tree
DLTR
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.29B |
| 2 |
Meta Platforms (Facebook)
META
|
+$1.85B |
| 3 |
Texas Instruments
TXN
|
+$1.82B |
| 4 |
Microsoft
MSFT
|
+$1.27B |
| 5 |
Booking.com
BKNG
|
+$1.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.76% |
| 2 | Technology | 16.79% |
| 3 | Consumer Discretionary | 15.26% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 9.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Open Text
OTEX
$6.02B
| $381K | ﹤0.01% |
10,031
+2,303
| +30% | +$87.9K |
|
2252
1st Source
SRCE
$2.13B
| $379K | ﹤0.01% |
7,201
+93
| +1% | +$5.18K |
|
|
EBIX
2253
DELISTED
Ebix Inc
EBIX
| $379K | ﹤0.01% |
4,784
-4,956
| -51% | -$395K |
|
|
CMO
2254
DELISTED
Capstead Mortgage Corp.
CMO
| $379K | ﹤0.01% |
47,897
+541
| +1% | +$4.56K |
|
2255
National Grid
NGG
$81.6B
| $377K | ﹤0.01% |
8,222
-345
| -4% | -$16.4K |
|
2256
E.W. Scripps
SSP
$310M
| $377K | ﹤0.01% |
22,848
-12,497
| -35% | -$181K |
|
2257
Oxford Industries
OXM
$542M
| $376K | ﹤0.01% |
4,167
+159
| +4% | +$14.5K |
|
2258
Camden National
CAC
$996M
| $375K | ﹤0.01% |
8,631
| – | – |
|
|
XOMA
2259
DELISTED
Xoma
XOMA
| $375K | ﹤0.01% |
21,337
+100
| +0.5% | +$2K |
|
|
CVIA
2260
DELISTED
Covia Holdings Corporation Common Stock
CVIA
| $374K | ﹤0.01% |
41,726
-510
| -1% | -$7.03K |
|
|
PIR
2261
DELISTED
Pier 1 Imports, Inc.
PIR
| $373K | ﹤0.01% |
12,438
-112
| -0.9% | -$4.44K |
|
|
UHT
2262
Universal Health Realty Income Trust
UHT
$573M
| $372K | ﹤0.01% |
5,001
+77
| +2% | +$5.42K |
|
2263
Interface
TILE
$2.24B
| $371K | ﹤0.01% |
15,896
+252
| +2% | +$5.85K |
|
|
VRS
2264
DELISTED
Verso Corporation
VRS
| $371K | ﹤0.01% |
+11,024
| New | +$288K |
|
|
SPPI
2265
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $370K | ﹤0.01% |
22,003
+703
| +3% | +$15.2K |
|
|
UMH
2266
UMH Properties
UMH
$1.42B
| $369K | ﹤0.01% |
23,571
+201
| +0.9% | +$3.16K |
|
|
OMN
2267
DELISTED
OMNOVA Solutions Inc.
OMN
| $369K | ﹤0.01% |
37,417
-132
| -0.4% | -$1.26K |
|
|
CJ
2268
DELISTED
C&J Energy Services, Inc.
CJ
| $369K | ﹤0.01% |
17,740
+278
| +2% | +$6.23K |
|
|
TTM
2269
DELISTED
Tata Motors Limited
TTM
| $368K | ﹤0.01% |
23,938
-9,300
| -28% | -$171K |
|
2270
Hawthorn Bancshares
HWBK
$277M
| $365K | ﹤0.01% |
19,546
| – | – |
|
2271
Movado Group
MOV
$796M
| $364K | ﹤0.01% |
8,682
+96
| +1% | +$4.5K |
|
|
PFC
2272
DELISTED
Premier Financial Corp. Common Stock
PFC
| $362K | ﹤0.01% |
12,034
-280
| -2% | -$9.01K |
|
2273
OneSpan
OSPN
$624M
| $358K | ﹤0.01% |
+18,767
| New | +$351K |
|
2274
RLI Corp
RLI
$5.87B
| $358K | ﹤0.01% |
9,118
+264
| +3% | +$9.9K |
|
|
DSPG
2275
DELISTED
DSP Group Inc
DSPG
| $358K | ﹤0.01% |
30,090
| – | – |
|
Similar funds
T. Rowe Price Associates's Q3 2018 Portfolio in Review
As of Q3 2018, T. Rowe Price Associates held 2,658 positions worth $685B, up 4.7% from $654B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q3 2018 filing shows 77 new, 1,268 increased, 1,098 reduced and 77 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M. The largest sale was Broadcom, an estimated $3.29B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 194,161 shares worth $208M.
- T. Rowe Price Associates added most to NVIDIA in Q3 2018, an estimated $2.47B increase.
- T. Rowe Price Associates's biggest Q3 2018 reduction was Broadcom, cutting an estimated $3.29B.
- T. Rowe Price Associates fully exited DCT Industrial Trust Inc. in Q3 2018, selling an estimated $345M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $685B portfolio in Q3 2018.
- T. Rowe Price Associates opened 77 new positions and closed 77 in Q3 2018.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $685B.
Based on T. Rowe Price Associates's 13F filing for Q3 2018, filed 14 Nov 2018.